Indirect T-cell allorecognition: Perspectives for peptide-based therapy in transplantation

被引:51
作者
Benichou, G
Tam, RC
Soares, LRB
Fedoseyeva, EV
机构
[1] ICN PHARMACEUT,COSTA MESA,CA 92626
[2] STANFORD UNIV,SCH MED,DEPT IMMUNOL & RHEUMATOL,PALO ALTO,CA 94305
来源
IMMUNOLOGY TODAY | 1997年 / 18卷 / 02期
关键词
D O I
10.1016/S0167-5699(97)01004-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Indirect allorecognition is nit important component of allotransplant rejection. Although the initial indirect alloresponse is limited to a fete dominant determinants on donor major histocompatibility complex (MHC) molecules, subsequent spreading to additional determinants on recipient and donor antigens is common. Gilles Benichou and colleagues discuss the mechanisms by which immunodominance is acquired or disrupted in indirect alloresponses, and examine the implications for the design of peptide-based selective immunotherapy in transplantation.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 34 条
  • [31] SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.iy.11.040193.002125
  • [32] INDIRECT PRESENTATION OF MHC ANTIGENS IN TRANSPLANTATION
    SHOSKES, DA
    WOOD, KJ
    [J]. IMMUNOLOGY TODAY, 1994, 15 (01): : 32 - 38
  • [33] Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs
    Sidney, J
    Grey, HM
    Kubo, RT
    Sette, A
    [J]. IMMUNOLOGY TODAY, 1996, 17 (06): : 261 - 266
  • [34] Tam RC, 1996, J IMMUNOL, V156, P3765